Finance

Lists
Why is MIRA down 3,22%?
Dive Deeper
MIRA:NASDAQ
Mira Pharmaceuticals Inc
0,71ย $
-3,22%
(-0,024) 1D
0,72ย $
+1,15% (+0,0082)
After hours
Closed: 6 ีฐีธีฏ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRA...
Open
0,76ย $
High
0,76ย $
Low
0,70ย $
Mkt. cap
29,51ย ีดีฌีถ
Avg. vol.
1,15ย ีดีฌีถ
Volume
0,00
52-wk high
2,45ย $
52-wk low
0,60ย $
EPS
-1,38ย $
Beta
1,48
Shares outstanding
42,02ย ีดีฌีถ
No. of employees
3
Open
0,76ย $
High
0,76ย $
Low
0,70ย $
Mkt. cap
29,51ย ีดีฌีถ
Avg. vol.
1,15ย ีดีฌีถ
Volume
0,00
52-wk high
2,45ย $
52-wk low
0,60ย $
EPS
-1,38ย $
Beta
1,48
Shares outstanding
42,02ย ีดีฌีถ
No. of employees
3
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
58 ึ€ีธีบีฅ ีกีผีกีป
AST SpaceMobile (ASTS) Completed Its First Direct Satellite To Smartphone Test In Canada
Simply Wall Street
Simply Wall Street
·
59 ึ€ีธีบีฅ ีกีผีกีป
AI Chips Update - Transforming Video Into Actionable Insights With Pegasus 1.6
Proactive financial news
Proactive financial news
·
22 ึ€ีธีบีฅ ีกีผีกีป
Jefferies maintains 'buy' rating on AstraZeneca ahead of third-quarter results
24/7 Wall St.
24/7 Wall St.
·
38 ึ€ีธีบีฅ ีกีผีกีป
Three Stocks Are Now 21% of the S&P 500, the Most Ever
About Mira Pharmaceuticals Inc
CEO-
Employees3
Founded2020
Headquartersี„ีกีตีกีดีซ, ี–ีฌีธึ€ีซีคีก, ี„ีซีกึีตีกีฌ ี†ีกีฐีกีถีฃีถีฅึ€
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to MIRA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MIRA in the last 3 months
Highest
Current 0,71ย $
3,50ย $ (+391,71%)
Average
3,50ย $ (+391,71%)
Lowest
3,50ย $ (+391,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Initiated
3,50ย $
+391,7%
09/17/2026
Michael King
Rodman & Renshaw
Buy
Initiated
8,00ย $
+1ย 023,9%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ีฉ. ีฝีฅีบ
2025 ีฉ. ีคีฅีฏ
2026 ีฉ. ีดึ€ีฟ
2026 ีฉ. ีฐีถีฝ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
412,64ย ีฐีฆึ€
496,54ย ีฐีฆึ€
524,78ย ีฐีฆึ€
705,79ย ีฐีฆึ€
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
904,35ย ีฐีฆึ€
5,33ย ีดีฌีถ
578,70ย ีฐีฆึ€
450,33ย ีฐีฆึ€
Operating expense
1,32ย ีดีฌีถ
5,82ย ีดีฌีถ
1,10ย ีดีฌีถ
1,16ย ีดีฌีถ
Total operating expenses
1,32ย ีดีฌีถ
5,82ย ีดีฌีถ
1,10ย ีดีฌีถ
1,16ย ีดีฌีถ
Operating income
-1,32ย ีดีฌีถ
-5,82ย ีดีฌีถ
-1,10ย ีดีฌีถ
-1,16ย ีดีฌีถ
Other non operating income
-12,44ย ีฐีฆึ€
-396,00
-
-
EBT including unusual items
-1,14ย ีดีฌีถ
-5,98ย ีดีฌีถ
-1,15ย ีดีฌีถ
-1,21ย ีดีฌีถ
EBT excluding unusual items
-1,31ย ีดีฌีถ
-5,77ย ีดีฌีถ
-1,15ย ีดีฌีถ
-1,21ย ีดีฌีถ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,14ย ีดีฌีถ
-5,98ย ีดีฌีถ
-1,15ย ีดีฌีถ
-1,21ย ีดีฌีถ
Net profit margin
-
-
-
-
Earnings per share
-0,07
-
-
-
Interest and investment income
15,70ย ีฐีฆึ€
53,17ย ีฐีฆึ€
44,91ย ีฐีฆึ€
35,13ย ีฐีฆึ€
Interest expense
-
-
-
-
Net interest expenses
15,70ย ีฐีฆึ€
53,17ย ีฐีฆึ€
44,91ย ีฐีฆึ€
35,13ย ีฐีฆึ€
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps